Long-term outcomes of ruxolitinib (RUX) therapy in patients (pts) with myelofibrosis (MF): 5-year update from COMFORT-I.

被引：0
|
作者：
Gupta, Vikas
Verstovsek, Srdan
Mesa, Ruben A.
Gotlib, Jason R.
DiPersio, John F.
Catalano, John V.
Deininger, Michael W. N.
Miller, Carole Brennan
Silver, Richard T.
Talpaz, Moshe
Winton, Elliott F.
Harvey, Jimmie Huling
Arcasoy, Murat.
Hexner, Elizabeth O.
Lyons, Roger M.
Paquette, Ronald
Raza, Azra
Kornacki, Deanna
Sun, Kang
Kantarjian, Hagop M.
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Mayo Clin, Scottsdale, AZ USA
[4] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA
[5] Washington Univ, Sch Med, St Louis, MO 63110 USA
[6] Frankston Hosp, Frankston, Australia
[7] Dept Clin Haematol, Frankston, Australia
[8] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[9] St Agnes Canc Inst, Baltimore, MD USA
[10] Weill Cornell Med Ctr, New York, NY USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[13] Birmingham Hematol Oncol Associates, Birmingham, AL USA
[14] Duke Univ, Hlth Syst, Durham, NC USA
[15] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[16] Canc Care Ctr South Texas, US Oncol, San Antonio, TX USA
[17] Univ Calif Los Angeles, Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA
[18] Columbia Univ, Med Ctr, New York, NY USA
[19] Incyte Corp, Wilmington, DE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7012
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Long Term Outcomes From A Single Chronic Ventilator Unit: A 5-Year Assessment
    Galiatsatos, P.
    Dababneh, D.
    Friedlander, T.
    Feller-Kopman, D. J.
    Kelly, D.
    Finucane, T.
    Bellantoni, M.
    Pearse, D. B.
    Greenough, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study
    Kiladjian, Jean-Jacques
    Zachee, Pierre
    Hino, Masayuki
    Pane, Fabrizio
    Masszi, Tamas
    Harrison, Claire N.
    Mesa, Ruben
    Miller, Carole B.
    Passamonti, Francesco
    Durrant, Simon
    Griesshammer, Martin
    Kirito, Keita
    Besses, Carlos
    Beatriz Moiraghi, Elena
    Rumi, Elisa
    Rosti, Vittorio
    Blau, Igor Wolfgang
    Francillard, Nathalie
    Dong, Tuochuan
    Wroclawska, Monika
    Vannucchi, Alessandro M.
    Verstovsek, Srdan
    LANCET HAEMATOLOGY, 2020, 7 (03): : E226 - E237
  • [43] Long-term outcomes of transvaginal mesh (TVM) In patients with pelvic organ prolapse: A 5-year follow-up
    Ubertazzi, Enrique P.
    Soderini, Hector F. E.
    Saavedra Sanchez, Adrian J. M.
    Fonseca Guzman, Camilo
    Pavan, Lucila, I
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 225 : 90 - 94
  • [44] Long-term outcomes after laparoscopic bile duct exploration: A 5-year follow up of 150 consecutive patients
    Campbell-Lloyd, Andrew J. M.
    Martin, David J.
    Martin, Ian J.
    ANZ JOURNAL OF SURGERY, 2008, 78 (06) : 492 - 494
  • [45] Long-term life and partnership satisfaction in infertile patients: a 5-year longitudinal study
    Schanz, Stefan
    Reimer, Thorisa
    Eichner, Martin
    Hautzinger, Martin
    Haefner, Hans-Martin
    Fierlbeck, Gerhard
    FERTILITY AND STERILITY, 2011, 96 (02) : 416 - 421
  • [46] High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
    Natsuo Tomita
    Norihito Soga
    Yuji Ogura
    Norio Hayashi
    Takumi Kageyama
    Makoto Ito
    Yutaro Koide
    Maiko Yoshida
    Kana Kimura
    Chiyoko Makita
    Hiroyuki Tachibana
    Takeshi Kodaira
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1609 - 1619
  • [47] High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
    Tomita, Natsuo
    Soga, Norihito
    Ogura, Yuji
    Hayashi, Norio
    Kageyama, Takumi
    Ito, Makoto
    Koide, Yutaro
    Yoshida, Maiko
    Kimura, Kana
    Makita, Chiyoko
    Tachibana, Hiroyuki
    Kodaira, Takeshi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1609 - 1619
  • [48] THE PROGRESSIVE BURDEN OF MYELOFIBROSIS (MF) IN UNTREATED PATIENTS: AN ASSESSMENT OF PATIENT-REPORTED OUTCOMES IN PLACEBO-TREATED PATIENTS FROM COMFORT-I
    Mesa, R.
    Shields, A.
    Hare, T.
    Erickson-Viitanen, S.
    Sun, W.
    Verstovsek, S.
    HAEMATOLOGICA, 2012, 97 : 153 - 153
  • [49] Long-term benefit of enzyme replacement therapy in Pompe disease A 5-year prospective study
    Kuperus, Esther
    Kruijshaar, Michelle E.
    Wens, Stephan C. A.
    de Vries, Juna M.
    Favejee, Marein M.
    van der Meijden, Jan C.
    Rizopoulos, Dimitris
    Brusse, Esther
    van Doorn, Pieter A.
    van der Ploeg, Ans T.
    van der Beek, Nadine A. M. E.
    NEUROLOGY, 2017, 89 (23) : 2365 - 2373
  • [50] Long-term changes in multimodal intensive tinnitus therapy A 5-year follow-up
    Brueggemann, P.
    Otto, J.
    Lorenz, N.
    Schorsch, S.
    Szczepek, A. J.
    Boecking, B.
    Mazurek, B.
    HNO, 2018, 66 : S34 - S38
12345